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Churg-Strauss syndrome is a small and medium vessel vasculitis that is also known as allergic granulomatous angiitis. It most
commonly presents with an asthma like symptoms. It was ﬁrst described in Mount Siani Hospital, New York in 1951 by Jacob
Churg and Lotte Stauss and was recognised after the study of a series of 13 patients who had asthma, eosinophilia, granulomatous
inﬂammation necrotising systemic vasculitis and necrotising glomerulonephritis. We describe a case of Churg-Strauss syndrome
presenting with abdominal pain and later during the hospital admission a mono-neuritis multiplex syndrome aﬀecting the lower
limbs. The patient presented in such an atypical fashion with abdominal signs and symptoms that they required laparotomy and
the diagnosis was made after histological examination of tissue taken at the time of surgery. Treatment with immunosuppression
and aggressive rehabilitation achieved a progressive recovery which continued on discharge from hospital.
1.Background
Churg-Strauss syndrome is a small and medium vessel vas-
culitis and is also known as allergic granulomatous angiitis.
It aﬀects small and medium size arteries and veins and
is closely related to both Wegners granulomatosis and the
microscopic form of periarteritis (microscopic polyangitis).
It is associated with perinuclear antineutrophil cytoplasmic
antibody (p-ANCA) positivity in up to 40%–50% of cases
[1].
The syndrome was ﬁrst described in Mount Siani
Hospital, New York in 1951 by Churg and Strauss [2]. It
was recognised after the study of a series of 13 patients
whohadasthma,eosinophilia, granulomatousinﬂammation
necrotising systemic vasculitis, and necrotising glomeru-
lonephritis.ItwasfurtherdescribedbyZeekin1952[3]asan
allergic granulomatous angiitis of a necrotic type and Zeek
speciﬁcally suggested that it diﬀered from hypersensitivity
vasculitis.Itpresentswithabroadrangeoflocalandsystemic
manifestations and is believed to have three phases. Initially
individuals have an asthma type illness often with allergic
rhinitis, this then progresses to conditions such as pneumo-
niaandgastroenteritiswhichareassociatedwitheosinophilic
inﬁltration. Finally a small and medium vessel vasculitis
arises with associated chronic granulomatous inﬂammation.
T h i sm a yb em a r k e db ys p e c i ﬁ ce n do r g a nd a m a g e ,f o r
example,renal,cardiac,pulmonary,dermatological,andvery
commonly a mononeuritis multiplex.
We present a case of Churg-Strauss syndrome presenting
with abdominal pain and later during the hospital admission
a mononeuritis multiplex syndrome aﬀecting the lower
limbs.
2.CaseReport
A 44-year-old man was assessed at our institution after
emergency referral by his general practitioner with a one
week history of left-sided abdominal and ﬂank pain with
pain spreading to the left thigh. There was a history of
a fever-like illness and some diarrhoea. He was apyrexial
at initial presentation however a fever developed later.
His past history consisted only of mild asthma managed
with metered dose steroid and bronchodilator inhalers and
allergic rhinitis. There was tenderness on palpation in the
left iliac fossa and left ﬂank and straight leg raise on the2 Case Reports in Medicine
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Figure 1: Coronal computerised tomography image showing
diﬀuse inﬂammation aﬀecting the peritoneum of the left side of
the abdomen, the pelvis and the left psoas and retroperitoneum.
(Marked by white arrow).
left intensiﬁed the pain. Initial investigations showed a raised
white count and a raised CRP of more than 100mg/L but
normal renal and hepatic function. He underwent chest
and abdominal radiography which showed loss of the left
psoas shadow but normal abdominal gas pattern and no
pneumoperitoneum.
An initial diagnosis of acute diverticulitis with an
associated inﬂammation or abscess within the left psoas
was made. Intravenous access was established; intravenous
ﬂuids,analgesiaandintravenousCo-Amoxiclav1.2gtds,and
Gentamicin 5mg/kg OD were administered.
The day after admission his pain had worsened partic-
ularly in the left thigh and increased weakness was noted
in the left thigh. At this point a CT of the abdomen and
pelvis was performed. This showed diﬀuse inﬂammation
aﬀecting the peritoneum of the left side of the abdomen,
the pelvis, and the left psoas and retroperitoneum, but
no collection was seen (Figure 1). The following day the
lowerlimbneurological symptoms worsenedwithnumbness
aﬀecting the L1/L2 distribution, quadriceps weakness on the
left, and similar weakness on the right side. An MRI of
the thoracolumbar and sacral spine was performed and an
opinion sought from the neurology service. The MRI did
not reveal any signiﬁcant abnormality of the spine or spinal
nerve roots and conﬁrmed the presence of inﬂammation
aﬀecting the left psoas, left sided retroperitoneum, and
associated left sided abdominal and pelvic peritoneum.
Repeat haematological investigations at this stage revealed
an eosinophilia that peaked at 4.52 × 109/L( N o r m a lr a n g e
0–0.5 × 109/L). The diﬀuse inﬂammation raised the pos-
sibility of inﬂammatory bowel disease and a colonoscopy
was performed at this time; however, the colon was both
macroscopically normal and random biopsies showed it to
be microscopically normal.
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Figure 2: High-powered image of haematoxylin and eosin-stained
section of a vessel with eosinophilic inﬁltrate and vascular distor-
tion, x225 magniﬁcation.
AtthisstageANA,p-ANCA,andc-ANCA,cryoglobulins,
complement studies, hepatitis screen, and serum protein
electrophoresis were all normal.
Over the following 24 hours his abdominal symptoms
and signs dramatically worsened and he became peritonitic;
concern about the possibility of mesenteric ischaemia was
raised and based on the clinical ﬁndings we proceeded to
laparotomy. 4 litres of ascites were immediately identiﬁed
at this point, which was thought to have arisen from a
diﬀuse inﬂammatory peritoneal response and associated
hypoalbuminaemia producing an ascitic transudate. The
ascites were drained and a sample sent for cytologi-
cal examination. Further examination of the abdominal
cavity revealed diﬀuse inﬂammatory inﬁltrate particularly
involving the appendix, small bowel, peritoneum, and
omentum. An appendicectomy was performed along with
sampling of the small bowel, peritoneum, and greater
omentum.
He recovered slowly, but there was continued persistence
of his neurological symptoms and pain. Cytology of the
ascitic ﬂuid showed numerous eosinophils, with histiocytes
and reactive mesothelial cells whilst histology from the
surgical samples which became available three days later
showed tissue with diﬀuse serosal coverage by an extensive
eosinophilic exudate which extended into the subserosa of
the excised appendix with an associated subserosal focal
eosinophilic vasculitis. H&E histological staining of tissue
containing vessels with eosinophilic inﬁltrate and distortion
is shown in Figure 2. Within the omental tissue in addition
to the eosinophilic inﬁltrate, occasional multinuclear giant
cell were seen. No mycobacteria, parasites, or other infective
organisms were seen.
These ﬁndings were strongly suggestive of Churg-Strauss
and a specialist opinion was sought from the Rheumatology
service at our institution. Pulsed intravenous methyl
prednisolone 1gtds was started and a plan made, once a
full recovery from the surgery had occurred, to convert to
oral prednisolone 50mg per day (reducing dose regime)
and cyclophosphamide 750mgiv together with prophylacticCase Reports in Medicine 3
Mesna 400mg before and after the cyclophosphamide. This
was initially planned at 2 weekly intervals and then monthly
according to response with regular monitoring of the platelet
count.
His recovery was unfortunately delayed by wound infec-
tion and then a wound dehiscence requiring resuturing
under general anaesthesia. Therefore, although the steroid
therapy was initiated immediately cyclophosphamide was
delayed until 4 weeks after the abdominal resuturing.
His quadriceps weakness slowly improved and a minor
improvement in sensation in the L1 and L2 distributions
were identiﬁed. He transferred to a rehabilitation facility
37 days after admission and 34 days after his laparotomy
and was discharged home after 48 days. A reducing dose
regime of oral prednisolone was prescribed on discharge,
starting at 50mg/day and reducing by 5mg per week and
plans for a reducing frequency cyclophosphamide infusion
made. On review at 6 weeks his surgical wounds had healed,
strength in his quadriceps had increased, and sensation
in the L1 and L2 dermatomes had almost returned to
normal.
3. Discussion
Churg-Strauss syndrome is rare and is deﬁned by six
criteria [4]: (1) bronchial asthma; (2) Eosinophilia >10% by
diﬀerential white cell count; (3) Mono- or polyneuropathy;
(4) Nonﬁxed pulmonary inﬁltrates on chest radiography; (5)
paranasal sinus abnormalities; (6) Biopsy containing blood
vessels with extravascular eosinophils [5, 6]. Presence of 4
out of 6 of these criteria has 99.7% speciﬁcity and an 85%
sensitivity for Churg-Strauss [6].
Our patient had four out of the six criteria described; the
only features he did not exhibit were nonﬁxed pulmonary
inﬁltrates on chest radiography. We did not investigate
him for paranasal sinus abnormalities, but he did have
allergic rhinitis. The peritoneal, omental, and appendiceal
biopsiesdidshowextravasculareosinophilicinﬁltratesandin
addition multinucleate giant cells were seen consistent with
the most advanced phase of Churg-Strauss syndrome in the
omental tissue sampled [7].
Churg-Strauss syndrome presents with a wide range of
symptoms, asthma aﬀects nearly all individuals (97%) and
may precede the vasculitis by up to 10 years, nearly two
thirds (61%) of individuals have sinusitis; allergic rhinitis
is also common but necrotizing lesions (typical of Wegners
granulomatosis)are,however,rarebutpolyposisiscommon.
Cough and haemoptysis occur in just over a third of
individuals (37%); arthralgias occur in 40% of patients,
whilst skin changes occur in half of all patients (49%).
Cardiac events may also occur and rarely Churg-Strauss may
aﬀect the eyes or even cause stroke.
Churg-Strauss manifests in the gastrointestinal tract in
31% of cases, causing abdominal pain as in our case,
diarrhoea, and occasionally gastrointestinal bleeding [8, 9].
The need for laparotomy is rare; in this case it might be
hypothesised that the severe local inﬂammation generated
signiﬁcant peritoneal irritation, producing signs initially
local and then diﬀusing peritonism. The dehiscence is an
additional unfortunate complication in our case and likely
reﬂects, overall poor nutritional state, high-dose steroid
therapy, and perhaps the systemic inﬂammatory eﬀect of the
underlying vasculitis.
Neuropathy is also common. There is commonly a
mononeuritis multiplex (77% of cases) but may be a
polyneuropathy as became apparent in this case.
There is a signiﬁcant eosinophilia, and often an anaemia;
ESR and CRP are raised; p (perinuclear)-ANCA is positive
in 40%–50% of cases; serum IgE may be raised and
there is often a hypergammaglobulinaemia. Rheumatoid
factor may be weakly positive and there are elevations in
eosinophils cationic protein, soluble interleukin-2 receptor
(sIL-2R), and soluble thrombomodulin which speciﬁcally
mark endothelial injury [10, 11].
Histopathologically Churg-Strauss syndrome is charac-
terised by small necrotizing granulomas, and necrotizing
vasculitis involving the small and medium vessels. The
granulomasconsistofacentraleosinophiliccoresurrounded
radially by macrophages and epitheliod giant cells, which
were a feature of our case [7].
Treatment involves immunosuppression and begins with
steroids; these may be oral if the manifestations are mild;
however these should be intravenous if there is major
organ involvement or neuropathy. Approximately 30% of
patients require more aggressive immunosuppression; these
are individuals who have severe disease or have failed to
respond to steroids. This is initially with cyclophosphamide
and is typically once weekly, and as a clinical response
is detected the frequency of administration is reduced
[12].
In addition, immunosuppression with azathioprine [13],
mycophenlotae [14] and intravenous immunoglobulin [15]
have also been used. A small number of cases of treatment
withinterferonalphahavebeenreportedbutthetrueeﬃcacy
remains unclear [16].
More recently a number of reports have suggested
immunomodulation using the genetically modiﬁed anti-
CD20 monoclonal antibody rituximab, and the chimeric
monoclonal anti-TNFα antibody inﬂiximab may oﬀer ben-
eﬁts in Churg-Strauss, in refractory cases and also by either
avoiding the use of cytotoxic agents or reducing steroid
dependency [17, 18].
In the long term this systemic vasculitis has a 90% 1 year
survival and a 62% 5 years survival, without treatment the
survival is signiﬁcantly diminished with 5 year survival being
only 25% [19]. Relapse is common, and long-term steroid
therapy is often required; nasal involvement often marks
a relatively good prognosis in Churg-Strauss syndrome,
which is in contrast to Wegner’s Granulomatosis whilst
gastrointestinal tract disease, as demonstrated in our case,
often marks a poorer long term outcome and increased risk
of relapse [20].
In summary we present a diagnostically challenging and
atypical case of Churg-Strauss syndrome presenting with
abdominal and ﬂank pain and a polyneuropathy which
required extensive investigation and laparotomy to achieve
a diagnosis.4 Case Reports in Medicine
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